Detalles de la búsqueda
1.
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
N Engl J Med
; 387(5): 421-432, 2022 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35921451
2.
Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.
J Sex Med
; 10(6): 1592-602, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23551622
3.
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Front Neurol
; 12: 705407, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34659081
4.
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial.
JAMA Neurol
; 75(10): 1206-1214, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29913017
5.
Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance.
Neuropharmacology
; 47(7): 1081-92, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15555642
6.
Impact of comorbidities on pharmacotherapy of painful diabetic neuropathy in clinical practice.
J Diabetes Complications
; 28(5): 698-704, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24862108
7.
Effectiveness of duloxetine compared with pregabalin and gabapentin in diabetic peripheral neuropathic pain: results from a German observational study.
Clin J Pain
; 30(10): 875-85, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24296910
8.
Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist.
Psychopharmacology (Berl)
; 227(1): 1-17, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23241647
9.
Tolerability aspects in duloxetine-treated patients with depression: Should one use a lower starting dose in clinical practice?
Expert Opin Drug Saf
; 11(5): 699-711, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22712514
10.
EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors.
Neuropharmacology
; 62(2): 1099-110, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22085888
11.
Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues.
Neuropharmacology
; 59(6): 367-74, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20493887
12.
The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents.
J Pharmacol Exp Ther
; 321(2): 716-25, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17308038
Resultados
1 -
12
de 12
1
Próxima >
>>